The article, “Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease”, explores innovative in vitro methods to study Krabbe disease (KD), a severe lysosomal storage disorder. Using induced pluripotent stem cells (iPSCs), the research develops human-based models that replicate key aspects of the disease, providing insights into its mechanisms and potential therapeutic approaches.
Overview of Krabbe Disease (KD)
Krabbe disease is caused by a deficiency in the lysosomal enzyme galactosylceramidase (GALC), which leads to the accumulation of toxic lipids, particularly psychosine, causing widespread demyelination and neurodegeneration. Symptoms include severe neurological decline, blindness, and death. Current treatments like hematopoietic stem cell transplantation (HSCT) are effective only in asymptomatic patients, highlighting the need for advanced models to understand and address disease pathology.
Study Objectives
The study aimed to:
- Create iPSC-derived myelinating organoids to model KD pathology.
- Investigate early mechanisms driving demyelination and globoid cell formation.
- Assess lysosomal and autophagy dysfunction in KD cells.
Key Methods and Findings
Myelinating Organoids
- Development: Myelinating organoids were cultured using KD and control iPSCs. These models recapitulate neurogenesis, astrogenesis, oligodendrogenesis, and myelination stages over 28 weeks.
- Findings: KD organoids exhibited early myelination defects characterized by shorter myelin internodes and reduced internode numbers. Over time, significant myelin loss and oligodendrocyte reductions were observed. Notably, these defects occurred without major lysosomal or autophagic dysfunction in early stages, suggesting unique mechanisms of demyelination.
Microglia and Globoid Cells
- iPSC-derived microglia were co-cultured with organoids to study globoid cell formation. Feeding microglia with GalCer induced globoid cells, which displayed lysosomal dysfunction and autophagy protein accumulation.
- Over time, globoid cells activated compensatory mechanisms, such as increased lysosome biogenesis, to manage GalCer overload.
Mechanistic Insights
- The study highlights the role of psychosine and GalCer accumulation in driving KD pathology.
- It demonstrates that globoid cells, hallmark features of KD, arise from impaired microglial responses to lipid overload.
- Unlike traditional lysosomal storage disorders, KD models showed minimal autophagic flux impairment or mTOR pathway dysregulation in early stages, underscoring the complexity of its pathology.
Implications for Therapy
These findings suggest:
- Potential for iPSC-derived models to evaluate therapeutic strategies targeting early demyelination and lipid metabolism.
- Combining HSCT with gene therapy or substrate reduction therapies may improve outcomes by addressing both systemic and cell-autonomous mechanisms.
Conclusion
This study advances the understanding of Krabbe disease by leveraging human iPSC-derived organoids and microglia. The models provide a robust platform for investigating KD pathology, exploring therapeutic interventions, and studying the interplay between demyelination, neuroinflammation, and globoid cell formation.
For more detailed information, you can access the full study here.
*The United Leukodystrophy Foundation is not liable for any inaccuracies or gaps in these overviews , which are offered “as is” without assurances on completeness, accuracy, or timeliness. For verification or detailed information, please consult the original articles directly.
As a leukodystrophy related nonprofit, the ULF provides awareness to scientific literature. Inclusion on our website does not imply endorsement of, or agreement with, the contents by the ULF.